1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Technology Transfer (STTR) Program is sponsored by National Cancer Institute (NCI) - NIH. The NCI STTR program provides seed funding for early-stage companies collaborating with non-profit research institutions to advance innovative cancer-related technologies. This can include digital health solutions, such as AI applications in cancer prevention and early detection.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Going Beyond Funding for Next-Generation Cancer Technologies Boosting the Economy and Driving Innovation Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26. 1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Latest Opportunities with SBIR NCI SBIR/STTR Training and Entrepreneurship Program (STEP) Webinar STEP provides application support and entrepreneurship training toward Phase I NCI SBIR/STTR submissions. Interested applicants are strongly encouraged to join the STEP webinar on September 15. Registration is required.
NCI SBIR/STTR Investor Initiatives Showcase Companies The NCI SBIR/STTR Investor Initiatives Program is specifically designed to connect funded companies with potential investors and strategic partners. Check out the 2026-2027 showcase companies to learn more.
NCI SBIR/STTR Strategic Breakthrough Awards The NCI SBIR/STTR Phase IIB Strategic Breakthrough Award is a first-of-its-kind funding mechanism designed to accelerate late-stage clinical development of technologies addressing pediatric and rare cancers. The application deadline is September 8, 2026. Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale.
Illumina used NCI SBIR funding to develop their next generation sequencing technology.
According to the current listing, eligibility includes: U. S. -based small businesses with 500 or fewer employees are eligible, requiring formal collaboration with a non-profit research institution. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: $300K–$400K for one year; Phase II: up to $2.25 million for two years; Phase IIB Bridge Award: $4.5 million over 2–3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Technology Transfer (STTR) Program is funded by National Cancer Institute (NCI) - NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article